Europe Breast Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Europe Breast Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Europe Breast Cancer Diagnostics Market, By Test Type (Imaging, Biopsy, Genomic Test, Blood Test, and Others), Type (Ductal In Situ Carcinoma, Invasive Ductal Carcinoma, Inflammatory Breast Cancer, and Metastatic Breast Cancer), End User (Hospitals, Clinics, Research and Academic Institutes, Diagnostic Centers, and Others) Distribution Channel (Direct Tender, Retail Sales, and Others), Country (Germany, France, U.K., Italy, Russia, Spain, Netherlands, Switzerland, Belgium, Turkey, Ireland, Rest of Europe) Industry Trends and Forecast to 2030.

Market Definition

Breast cancer is a disease in which the uncontrolled growth of malignant cells in the breast tissue occurs more often in women than in men. Breast cancer is the uncontrolled cell division of breast cells, which are the most common cells in the mammary glands and ducts. Some symptoms of breast cancer include a lump or lump in the breast, bloody discharge from the nipple and a change in the shape of the nipple or breast. Breast cancer treatment depends on the stage of cancer. Its treatment consists of chemotherapy, radiation therapy, hormone therapy, and surgery.

Breast cancer is another type of cancer that is more common in women than in men. A number of the symptoms of the sickness hold bleeding secretion from the reproductive organ, a lump or block within the breast, and variations in the texture or form of the breast or nipple. Breast cancer treatment depends on the stage of cancer. In addition, its treatment includes radiotherapy, therapy, hormone therapy and surgery. Early detection of carcinoma is essential for the effective treatment of the disease. Early detection of the disease also leads to better outcomes, including many treatment options, better survival and better quality of life. Increasing pressure and demand for new forms of treatment or methods of treatment are due to the rapidly increasing spread of diseases.

Market Segmentation

The Europe breast cancer diagnostic market is segmented into four notable segments which are based on test type, type, end user, and distribution channel.
• On the basis of test type, the Europe breast cancer diagnostic market is segmented into imaging, biopsy, genomic test, blood tests and others
• On the basis of type, the Europe breast cancer diagnostic market is segmented into ductal in situ carcinoma, invasive ductal carcinoma, inflammatory breast cancer, and metastatic breast cancer
• On the basis of end user, the Europe breast cancer diagnostic market is segmented into hospitals, clinics, research and academic institutes, diagnostic centres and others
• On the basis of distribution channel, the Europe breast cancer diagnostic market is segmented into direct tender, retail sales and others

Market Players

Some of the major players operating in the Europe breast cancer diagnostic market are:
• Provista Diagnostics
• Thermo Fisher Scientific Inc.
• Myriad Genetics, Inc.
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• BD
• NanoString.
• Cepheid
• BIOMÉRIEUX


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The Europe Breast Cancer Diagnostic Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Market End User Coverage Grid
2.8 Test Type Lifeline Curve
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter's 5 Forces
5 Epidemiology
6 Industrial Insights
7 Regulatory Framework
8 Market Overview
8.1 Drivers
8.1.1 Launch Of Technologically Advanced Diagnosis & Therapeutics To Aid Growth
8.1.2 Increasing Prevalence Of Breast Cancer
8.1.3 Growing Importance Of Women's Health
8.1.4 Rising Awareness Towards The Breast Cancer
8.2 Restraints
8.2.1 Adverse Effects Of Breast Cancer Therapeutics
8.2.2 High Cost Of The Imaging Systems
8.3 Opportunities
8.3.1 Initiatives Taken By The Government
8.3.2 Strategic Initiatives Taken By The Key Market Players
8.3.3 Growth In Research And Development Of Breast Cancer
8.4 Challenges
8.4.1 Lack Of Diagnostic Infrastructure
8.4.2 Lack Of Skilled Professionals For Proper Diagnosis Of Breast Cancer
9 Europe Breast Cancer Diagnostics Market, By Test Type
9.1 Overview
9.2 Imaging
9.2.1 Ionizing Breast Imaging Technologies
9.2.1.1 Full-field Digital Mammography (Ffdm)
9.2.1.2 Analog Mammography
9.2.1.3 3d Breast Tomosynthesis
9.2.1.4 Positron Emission Tomography/ Computed Tomography (Pet/Ct)
9.2.1.5 Molecular Breast Imaging/ Breast Specific Gamma Imaging (Mbi/Bsmi)
9.2.1.6 Positron Emission Mammography
9.2.1.7 Others
9.2.2 Non-ionizing Imaging Technologies
9.2.2.1 Optical Imaging
9.2.2.2 Breast Ultrasound
9.2.2.3 Breast Mri (Magnetic Resonance Imaging)
9.2.2.4 Automated Whole Breast Ultrasound (Awbu)
9.2.2.5 Breast Thermography
9.2.3 Biopsy
9.2.3.1 Surgical Biopsy
9.2.3.2 Fine Needle Aspiration Biopsy
9.2.3.3 Core Needle Biopsy
9.2.3.4 Image-guided Biopsy
9.2.3.5 Sentinel Lymph Node Biopsy
9.2.4 Genomic Test
9.2.4.1 Molecular Testing
9.2.4.1.1 Pd-l1
9.2.4.1.2 Microsatellite Instability-high (Msi-h) Or Dna Mismatch Repair Deficiency (Dmmr)
9.2.4.1.3 Ntrk Gene Fusions
9.2.4.1.4 Pi3kca Gene Mutation
9.2.4.2 Mammaprint
9.2.4.3 Oncotype Dx
9.2.4.4 Others
9.3 Blood Test
9.4 Others
10 Europe Breast Cancer Diagnostics Market, By Type
10.1 Overview
10.2 Invasive Ductal Carcinoma
10.3 Ductal Carcinoma In Situ
10.4 Inflammatory Breast Cancer
10.5 Metastatic Breast Cancer
11 Europe Breast Cancer Diagnostics Market, By End User
11.1 Overview
11.2 Hospitals
11.3 Diagnostics Centers
11.4 Clinics
11.5 Research & Academic Institutes
11.6 Others
12 Europe Breast Cancer Diagnostics Market, By Distribution Channel
12.1 Overview
12.2 Direct Tender
12.3 Retail Sales
12.4 Others
13 Europe Breast Cancer Diagnostics Market, By Region
13.1 Europe
13.1.1 Germany
13.1.2 France
13.1.3 Russia
13.1.4 Italy
13.1.5 U.K.
13.1.6 Spain
13.1.7 Turkey
13.1.8 Netherlands
13.1.9 Belgium
13.1.10 Switzerland
13.1.11 Ireland
13.1.12 Rest Of Europe
14 Europe Breast Cancer Diagnostics Market, Company Landscape
14.1 Company Share Analysis: Europe
15 Swot Analysis
16 Company Profile
16.1 Hologic, Inc.
16.1.1 Company Snapshot
16.1.2 Revenue Analysis
16.1.3 Company Share Analysis
16.1.4 Product Portfolio
16.1.5 Recent Developments
16.2 Siemens Healthcare Gmbh
16.2.1 Company Snapshot
16.2.2 Revenue Analysis
16.2.3 Company Share Analysis
16.2.4 Product Portfolio
16.2.5 Recent Developments
16.3 F. Hoffmann- La Roche Ltd
16.3.1 Company Snapshot
16.3.2 Revenue Analysis
16.3.3 Company Share Analysis
16.3.4 Product Portfolio
16.3.5 Recent Developments
16.4 Koninklijke Philips N.V.
16.4.1 Company Snapshot
16.4.2 Revenue Analysis
16.4.3 Company Share Analysis
16.4.4 Product Portfolio
16.4.5 Recent Developments
16.5 Abbott
16.5.1 Company Snapshot
16.5.2 Revenue Analysis
16.5.3 Company Share Analysis
16.5.4 Product Portfolio
16.5.5 Recent Developments
16.6 Abacus Als
16.6.1 Company Snapshot
16.6.2 Product Portfolio
16.6.3 Recent Developments
16.7 Bd
16.7.1 Company Snapshot
16.7.2 Revenue Analysis
16.7.3 Company Share Analysis
16.7.4 Product Portfolio
16.7.5 Recent Developments
16.8 Biocept, Inc.
16.8.1 Company Snapshot
16.8.2 Revenue Analysis
16.8.3 Product Portfolio
16.8.4 Recent Developments
16.9 Biomérieux
16.9.1 Company Snapshot
16.9.2 Revenue Analysis
16.9.3 Product Portfolio
16.9.4 Recent Developments
16.10 Bio-rad Laboratories, Inc.
16.10.1 Company Snapshot
16.10.2 Revenue Analysis
16.10.3 Product Portfolio
16.10.4 Recent Development
16.11 Cepheid
16.11.1 Company Snapshot
16.11.2 Revenue Analysis
16.11.3 Product Portfolio
16.11.4 Recent Development
16.12 Exact Sciences Corporation
16.12.1 Company Snapshot
16.12.2 Revenue Analysis
16.12.3 Company Share Analysis
16.12.4 Product Portfolio
16.12.5 Recent Developments
16.13 Fujifilm Corporation
16.13.1 Company Snapshot
16.13.2 Revenue Analysis
16.13.3 Product Portfolio
16.13.4 Recent Development
16.14 General Electric
16.14.1 Company Snapshot
16.14.2 Revenue Analysis
16.14.3 Product Portfolio
16.14.4 Recent Developments
16.15 Illumina, Inc.
16.15.1 Company Snapshot
16.15.2 Revenue Analysis
16.15.3 Product Portfolio
16.15.4 Recent Developments
16.16 Myriad Genetics, Inc.
16.16.1 Company Snapshot
16.16.2 Revenue Analysis
16.16.3 Product Portfolio
16.16.4 Recent Development
16.17 Nanostring.
16.17.1 Company Snapshot
16.17.2 Revenue Analysis
16.17.3 Product Portfolio
16.17.4 Recent Development
16.17.5 Recent Development
16.18 Oncostem.
16.18.1 Company Snapshot
16.18.2 Product Portfolio
16.18.3 Recent Development
16.19 Provista Diagnostics.
16.19.1 Company Snapshot
16.19.2 Product Portfolio
16.19.3 Recent Development
16.20 Thermo Fisher Scientific Inc.
16.20.1 Company Snapshot
16.20.2 Revenue Analysis
16.20.3 Product Portfolio
16.20.4 Recent Development
17 Questionnaire
18 Related Reports 244
List Of Tables
Table 1 Incidence Rate Of Breast Cancer (2020)
Table 2 Mortality Rate Of Breast Cancer (2020)
Table 3 Incidence Of Ductal Carcinoma In Situ (Dcis) Breast Cancer
Table 4 Europe Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 5 Europe Imaging In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 6 Europe Imaging In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 7 Europe Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 8 Europe Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 9 Europe Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 10 Europe Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 11 Europe Biopsy In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 12 Europe Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 13 Europe Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 14 Europe Genomic Test In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 15 Europe Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 16 Europe Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 17 Europe Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 18 Europe Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 19 Europe Blood Test In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 20 Europe Others In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 21 Europe Breast Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
Table 22 Europe Invasive Ductal Carcinoma In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 23 Europe Ductal Carcinoma In Situ In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 24 Europe Inflammatory Breast Cancer In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 25 Europe Metastatic Breast Cancer In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 26 Europe Breast Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 27 Europe Hospitals In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 28 Europe Diagnostic Centers In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 29 Europe Clinics In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 30 Europe Research And Academic Institutes In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 31 Europe Others In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 32 Europe Breast Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 33 Europe Direct Tender In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 34 Europe Retail Sales In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 35 Europe Others In Breast Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 36 Europe Breast Cancer Diagnostics Market, By Country, 2021-2030 (Usd Million)
Table 37 Europe Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 38 Europe Imaging In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 39 Europe Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 40 Europe Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 41 Europe Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 42 Europe Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 43 Europe Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 44 Europe Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 45 Europe Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 46 Europe Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 47 Europe Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 48 Europe Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 49 Europe Breast Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
Table 50 Europe Breast Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 51 Europe Breast Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 52 Germany Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 53 Germany Imaging In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 54 Germany Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 55 Germany Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 56 Germany Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 57 Germany Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 58 Germany Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 59 Germany Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 60 Germany Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 61 Germany Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 62 Germany Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 63 Germany Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 64 Germany Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 65 Germany Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 66 Germany Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 67 Germany Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 68 Germany Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 69 Germany Breast Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
Table 70 Germany Breast Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 71 Germany Breast Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 72 France Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 73 France Imaging In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 74 France Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 75 France Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 76 France Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 77 France Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 78 France Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 79 France Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 80 France Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 81 France Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 82 France Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 83 France Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 84 France Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 85 France Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 86 France Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 87 France Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 88 France Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 89 France Breast Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
Table 90 France Breast Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 91 France Breast Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 92 Russia Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 93 Russia Imaging In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 94 Russia Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 95 Russia Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 96 Russia Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 97 Russia Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 98 Russia Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 99 Russia Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 100 Russia Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 101 Russia Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 102 Russia Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 103 Russia Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 104 Russia Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 105 Russia Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 106 Russia Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 107 Russia Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 108 Russia Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 109 Russia Breast Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
Table 110 Russia Breast Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 111 Russia Breast Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 112 Italy Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 113 Italy Imaging In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 114 Italy Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 115 Italy Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 116 Italy Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 117 Italy Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 118 Italy Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 119 Italy Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 120 Italy Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 121 Italy Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 122 Italy Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 123 Italy Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 124 Italy Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 125 Italy Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 126 Italy Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 127 Italy Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 128 Italy Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 129 Italy Breast Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
Table 130 Italy Breast Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 131 Italy Breast Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 132 U.K. Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 133 U.K. Imaging In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 134 U.K. Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 135 U.K. Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 136 U.K. Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 137 U.K. Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 138 U.K. Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 139 U.K. Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 140 U.K. Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 141 U.K. Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 142 U.K. Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 143 U.K. Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 144 U.K. Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 145 U.K. Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 146 U.K. Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 147 U.K. Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 148 U.K. Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 149 U.K. Breast Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
Table 150 U.K. Breast Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 151 U.K. Breast Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 152 Spain Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 153 Spain Imaging In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 154 Spain Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 155 Spain Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 156 Spain Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 157 Spain Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 158 Spain Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 159 Spain Non-ionizing Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 160 Spain Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 161 Spain Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 162 Spain Biopsy In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 163 Spain Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 164 Spain Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 165 Spain Genomic Test In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 166 Spain Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 167 Spain Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 Asp
Table 168 Spain Molecular Testing In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Units)
Table 169 Spain Breast Cancer Diagnostics Market, By Type, 2021-2030 (Usd Million)
Table 170 Spain Breast Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 171 Spain Breast Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 172 Turkey Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 173 Turkey Imaging In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 174 Turkey Ionizing Breast Imaging Technologies In Breast Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
List Of Figures
Figure 1 Europe Breast Cancer Diagnostic Market: Segmentation
Figure 2 Europe Breast Cancer Diagnostic Market: Data Triangulation
Figure 3 Europe Breast Cancer Diagnostic Market: Droc Analysis
Figure 4 Europe Breast Cancer Diagnostic Market: Europe Vs Regional Market Analysis
Figure 5 Europe Breast Cancer Diagnostic Market: Company Research Analysis
Figure 6 Europe Breast Cancer Diagnostic Market: Interview Demographics
Figure 7 Europe Breast Cancer Diagnostic Market: Market End User Coverage Grid
Figure 8 Europe Breast Cancer Diagnostic Market: Dbmr Market Position Grid
Figure 9 Europe Breast Cancer Diagnostic Market: Vendor Share Analysis
Figure 10 Europe Breast Cancer Diagnostic Market: Segmentation
Figure 11 Growing Awareness Of Breast Cancer And Increasing Healthcare Expenditure Is Expected To Drive The Growth Of The Europe Breast Cancer Diagnostic Market From 2023 To 2030
Figure 12 The Imaging Segment Is Expected To Account For The Largest Share Of The Europe Breast Cancer Diagnostic Market In 2023 & 2030
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Europe Breast Cancer Diagnostics Market
Figure 14 Europe Breast Cancer Diagnostics Market : By Test Type, 2022
Figure 15 Europe Breast Cancer Diagnostics Market : By Test Type, 2023-2030 (Usd Million)
Figure 16 Europe Breast Cancer Diagnostics Market : By Test Type, Cagr (2023-2030)
Figure 17 Europe Breast Cancer Diagnostics Market : By Test Type, Lifeline Curve
Figure 18 Europe Breast Cancer Diagnostics Market : By Type, 2022
Figure 19 Europe Breast Cancer Diagnostics Market : By Type, 2023-2030 (Usd Million)
Figure 20 Europe Breast Cancer Diagnostics Market : By Type, Cagr (2023-2030)
Figure 21 Europe Breast Cancer Diagnostics Market : By Type, Lifeline Curve
Figure 22 Europe Breast Cancer Diagnostics Market : By End User, 2022
Figure 23 Europe Breast Cancer Diagnostics Market : By End User, 2023-2030 (Usd Million)
Figure 24 Europe Breast Cancer Diagnostics Market : By End User, Cagr (2023-2030)
Figure 25 Europe Breast Cancer Diagnostics Market : By End User, Lifeline Curve
Figure 26 Europe Breast Cancer Diagnostics Market : By Distribution Channel, 2022
Figure 27 Europe Breast Cancer Diagnostics Market : By Distribution Channel, 2023-2030 (Usd Million)
Figure 28 Europe Breast Cancer Diagnostics Market : By Distribution Channel, Cagr (2023-2030)
Figure 29 Europe Breast Cancer Diagnostics Market : By Distribution Channel, Lifeline Curve
Figure 30 Europe Breast Cancer Diagnostics Market: Snapshot (2022)
Figure 31 Europe Breast Cancer Diagnostics Market: By Country (2022)
Figure 32 Europe Breast Cancer Diagnostics Market: By Country (2023 & 2030)
Figure 33 Europe Breast Cancer Diagnostics Market: By Country (2022 & 2030)
Figure 34 Europe Breast Cancer Diagnostics Market: Test Type (2023-2030)
Figure 35 Europe Breast Cancer Diagnostics Market: Company Share 2022 (%) 174

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings